Literature DB >> 31424116

Transcriptomic Analysis of Cellular Pathways in Healing Flexor Tendons of Plasminogen Activator Inhibitor 1 (PAI-1/Serpine1) Null Mice.

Margaret A T Freeberg1,2, Anas Easa2, Jacquelyn A Lillis3, Danielle S W Benoit1,2, Andre J van Wijnen4, Hani A Awad1,2,5.   

Abstract

Injuries to flexor tendons can be complicated by fibrotic adhesions, which severely impair the function of the hand. Plasminogen activator inhibitor 1 (PAI-1/SERPINE1), a master suppressor of fibrinolysis and protease activity, is associated with adhesions. Here, we used next-generation RNA sequencing (RNA-Seq) to assess genome-wide differences in messenger RNA expression due to PAI-1 deficiency after zone II flexor tendon injury. We used the ingenuity pathway analysis to characterize molecular pathways and biological drivers associated with differentially expressed genes (DEG). Analysis of hundreds of overlapping and DEG in PAI-1 knockout (KO) and wild-type mice (C57Bl/6J) during tendon healing revealed common and distinct biological processes. Pathway analysis identified cell proliferation, survival, and senescence, as well as chronic inflammation as potential drivers of fibrotic healing and adhesions in injured tendons. Importantly, we identified the activation of PTEN signaling and the inhibition of FOXO1-associated biological processes as unique transcriptional signatures of the healing tendon in the PAI-1/Serpine1 KO mice. Further, transcriptomic differences due to the genetic deletion of PAI-1 were mechanistically linked to PI3K/Akt/mTOR, PKC, and MAPK signaling cascades. These transcriptional observations provide novel insights into the biological roles of PAI-1 in tendon healing and could identify therapeutic targets to achieve scar-free regenerative healing of tendons.
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:43-58, 2020. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  FOXO1; PAI-1; PTEN; RNA sequencing; adhesions; fibrosis; ingenuity pathway analysis; tendon

Mesh:

Substances:

Year:  2019        PMID: 31424116      PMCID: PMC7364818          DOI: 10.1002/jor.24448

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  48 in total

1.  Recent progress in flexor tendon healing.

Authors:  Matthew J Silva; Martin I Boyer; Richard H Gelberman
Journal:  J Orthop Sci       Date:  2002       Impact factor: 1.601

2.  Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.

Authors:  David T Berg; Laura J Myers; Mark A Richardson; George Sandusky; Brian W Grinnell
Journal:  J Biol Chem       Date:  2005-02-16       Impact factor: 5.157

Review 3.  TGF-beta and fibrosis.

Authors:  M H Branton; J B Kopp
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

4.  The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1.

Authors:  G C Prendergast; L E Diamond; D Dahl; M D Cole
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

5.  MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.

Authors:  Baoliang Guo; Ken Inoki; Motohide Isono; Hiroyuki Mori; Keizo Kanasaki; Toshiro Sugimoto; Satoshi Akiba; Takashi Sato; Baofeng Yang; Ryuichi Kikkawa; Atsunori Kashiwagi; Masakazu Haneda; Daisuke Koya
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

6.  Inhibition of p38 mitogen-activated protein kinase signaling reduces fibrosis and lipid accumulation after rotator cuff repair.

Authors:  Jeffrey M Wilde; Jonathan P Gumucio; Jeremy A Grekin; Dylan C Sarver; Andrew C Noah; David G Ruehlmann; Max E Davis; Asheesh Bedi; Christopher L Mendias
Journal:  J Shoulder Elbow Surg       Date:  2016-04-07       Impact factor: 3.019

7.  Cell proliferation is a key determinant of the outcome of FOXO3a activation.

Authors:  Raewyn C Poulsen; Andrew J Carr; Philippa A Hulley
Journal:  Biochem Biophys Res Commun       Date:  2015-04-30       Impact factor: 3.575

8.  Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stress.

Authors:  K Rajesh; J Krishnamoorthy; U Kazimierczak; C Tenkerian; A I Papadakis; S Wang; S Huang; A E Koromilas
Journal:  Cell Death Dis       Date:  2015-01-15       Impact factor: 8.469

Review 9.  Protein kinase C isoforms: Multi-functional regulators of cell life and death.

Authors:  Mary E Reyland
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53.

Authors:  Seung Hee Jung; Hyun Jung Hwang; Donghee Kang; Hyun A Park; Hyung Chul Lee; Daecheol Jeong; Keunwook Lee; Heon Joo Park; Young-Gyu Ko; Jae-Seon Lee
Journal:  Oncogene       Date:  2018-10-18       Impact factor: 9.867

View more
  5 in total

1.  NF-κB activation persists into the remodeling phase of tendon healing and promotes myofibroblast survival.

Authors:  Katherine T Best; Anne E C Nichols; Emma Knapp; Warren C Hammert; Constantinos Ketonis; Jennifer H Jonason; Hani A Awad; Alayna E Loiselle
Journal:  Sci Signal       Date:  2020-11-17       Impact factor: 8.192

2.  Atorvastatin Inhibits Endothelial PAI-1-Mediated Monocyte Migration and Alleviates Radiation-Induced Enteropathy.

Authors:  Seo Young Kwak; Sunhoo Park; Hyewon Kim; Sun-Joo Lee; Won-Suk Jang; Min-Jung Kim; SeungBum Lee; Won Il Jang; Ah Ra Kim; Eun Hye Kim; Sehwan Shim; Hyosun Jang
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

Review 3.  Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective.

Authors:  Seyed Hootan Hamidi; Sandhya Kadamboor Veethil; Seyedeh Harir Hamidi
Journal:  Pharmacol Rep       Date:  2021-04-21       Impact factor: 3.919

4.  Altered TGFB1 regulated pathways promote accelerated tendon healing in the superhealer MRL/MpJ mouse.

Authors:  Jacob G Kallenbach; Margaret A T Freeberg; David Abplanalp; Rahul G Alenchery; Raquel E Ajalik; Samantha Muscat; Jacquelyn A Myers; John M Ashton; Alayna Loiselle; Mark R Buckley; Andre J van Wijnen; Hani A Awad
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

5.  End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression.

Authors:  Ruijing Zhang; Jason Saredy; Ying Shao; Tian Yao; Lu Liu; Fatma Saaoud; William Y Yang; Yu Sun; Candice Johnson; Charles Drummer; Hangfei Fu; Yifan Lu; Keman Xu; Ming Liu; Jirong Wang; Elizabeth Cutler; Daohai Yu; Xiaohua Jiang; Yafeng Li; Rongshan Li; Lihua Wang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.